Neuronal ceroid lipofuscinosis 8 northern epilepsy variant

MONDO:0012391

Progressive epilepsy-intellectual deficit, Finnish type (also known as Northern epilepsy) is a subtype of neuronal ceroid lipofuscinosis (NCL) characterized by seizures, progressive decline of intellectual capacities and variable loss of vision.

Also known as: CLN8 disease, Northern epilepsy variant, EPMR, NCL, Northern epilepsy variant, Northern epilepsy, early onset familial encephalopathy with neuroserpin inclusion bodies, neuronal ceroid lipofuscinosis, Northern epilepsy variant, progressive epilepsy with intellectual disability, northern epilepsy, progressive epilepsy-intellectual disability syndrome, Finnish type

54 clinical trials for this condition and its sub-types.

Follow this condition — get notified about new trials

Broader categories

Disease (618) Epilepsy (398) Nervous system disorder (217) Metabolic disease (215) Hereditary disease (172) Inherited lipid metabolism disorder (165) Neurodegenerative disease (155) Brain disorder (110) Central nervous system disorder (97) Inborn errors of metabolism (42)

Trials to join now! 25 Not yet recruiting 5 Not yet finished but already full! 8 Completed 16

Neuronal ceroid lipofuscinosis 8 northern epilepsy variant

Broader categories

Real-World study tracks Epidyolex's Long-Term impact on seizures

AI boosts brain scan accuracy in massive new trial

New vitamin supplements aim to make life easier for kids with rare metabolic disorders

Could a headset at home boost brain recovery? new study tests tDCS for stroke, tumors, and neurodegeneration

NIH launches major study to unravel mysteries of rare genetic diseases

Massive genetic study aims to unlock secrets of rare metabolic diseases

Study on COVID-19 and metabolic disorders pulled before it began

300 volunteers help create medical image bank for science